←
Affera61 posts
Affera avatar

Affera

@AfferaEP

Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing cardiac arrhythmia market.

◷ Joined January 2020▧ 6 Photos and videos
Affera avatar
Affera@AfferaEP·15 Mar 2023

Medtronic receives CE mark approval for the Affera™ Mapping and Ablation System! Find the latest on Affera technologies and clinical programs by following us at @MDT_EPAblation and @medtroniceu #EPeeps #afferaCEmark #affera

Affera™ mapping and ablation system, which includes the Sphere-9™ all-in-one mapping and therapeutic radiofrequency (RF) and pulsed field (PF) ablation catheter, receives CE Mark approval! https://t.co/tSTODAUD3G

Post attachment
Rebecca Seidel avatar
⟳ Affera retweeted
Rebecca Seidel@SeidelRebecca·26 Apr 2023

Thrilled the first Affera System case took place at Medical Center Hamburg-Eppendorf. Congrats to @AndreasMetzner7 & team. This is the first of sites to come in the next few weeks. Excited to make a difference for patients with this novel innovation #MedtronicEmployee #EPeeps

Thrilled to share that we are the first center worldwide who performed ablation procedures with the Medtronic Affera Mapping and Ablation system! Congratulations to our great team and Medtronic, great achievement! #Affera #PFA #innovationinhealthcare #electrophysiology #EPeeps

Post attachment
Felix Yang, MD, FACC, FHRS avatar
⟳ Affera retweeted
Felix Yang, MD, FACC, FHRS@FYang_EP·14 Jun 2022

Thoughts after first cases w Affera: 1) having all in one mapping/ablating globe is super efficient (mapped an LAA AT and two SVC ATs on first case- first burn terminations on all three) 2) mapping definition and annotation algorithm is on the money as evidenced above

Dinesh Sharma MD MPH FHRS avatar
⟳ Affera retweeted
Dinesh Sharma MD MPH FHRS@DineshSharmaEP·15 Feb 2022

I am fortunate to be a site prinicipal investigator for AFFERA's disruptive pulse-field/radiofrequency atrial fibrillation ablation clinical trial. The cardiac electrophysiology community across the world is looking forward to this trial. I had our cent…lnkd.in/e36Sdvyc

Jacob Koruth avatar
⟳ Affera retweeted
Jacob Koruth@jskoruth·29 Jul 2021

Dose dependent reversible electroporation - effect on AV node conduction. Follow up from last years data on egm amplitude - transient AV block after the pulse that reverses in <1-2 minutes

Post attachment
Affera avatar
Affera@AfferaEP·25 Jul 2021

Affera ready to redefine another catheter ablation category. Thank you Drs. Aidietis and Račkauskas at Vilnius University Hospital for hosting us and @EladAnter and @VivekReddyMD for joining us to perform successful FIH procedures last week. Stay tuned…

Post attachment
Elad Anter avatar
⟳ Affera retweeted
Elad Anter@EladAnter·6 Mar 2021

Another PerAF case with Affera PFA: PVI+PWI+MAL: 1st to last lesion <30min with total procedure time <1Hr including mapping and 20min waiting period (no reconnections). We may soon be ready to re-evaluate ablation strategies to treat different types of AF w/ rapid and durable Tx.

0:26